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Functional multimodal imaging was used to assess early 
response to radiation treatment in the murine prostate 
tumour model CWR22.  
Positron Emission Tomography (PET)/Computer Tomography 
(CT) and Dynamic Contrast-Enhanced Ultrasonography (DCE-
US) were employed to determine the relationship between 
metabolic and microvascular parameters that reflect the 
tumour microenvironment, followed by immunohistochemical 
validation of microvessel density (MVD) and necrosis. Two 
experimental groups were tested according to the tracers 
used in PET/CT: 18Fluorine-Fluoromisonidazole (18F-FMISO) 
and 18F-Fluorocholine (18F-FCH) which are associated with 
hypoxia and choline metabolism, respectively [1,2]. PET/CT 
and DCE-US were acquired at day 0 and day 3. At day 1, 
radiation treatment was delivered as a single fraction of 10 
Gy. PET/CT and DCE-US acquisition and quantification were 
performed as previously described [3,4]. Wilcoxon’s 
matched-pairs test was used to determine intergroup 
differences at day 0 and day 3, and to assess intragroup 
differences from day 0 to day 3. Kendall’s Tau-b test was 
employed to assess correlation between functional 
parameters derived from PET/CT and DCE-US. In addition, 
the relationship between functional and histological 
parameters was also tested. Bonferroni correction for 
multiple testing was employed and a significance level of 5% 
was considered in all tests. 
In the 18F-FMISO group, the maximum Standardized Uptake 
Values (SUVmax) and the mean SUV (SUVmean) were 
decreased for the treated mice, suggesting a decrease in 
hypoxia. Furthermore, the SUVmean of the tumour-to-muscle 
ratio was correlated to MVD at day 3. In addition, the 
eliminating rate constant of the contrast agent from the 
plasma kel derived from DCE-US was correlated to the 
SUVmean of tumour-to-muscle ratio, necrosis, and MVD. In 
the 18F-FCH group; heterogeneous and reduced tracer uptake 
was detected. The kurtosis of the amplitude of the contrast 
uptake A linked to DCE-US was significantly decreased for the 
control mice.  
Our results demonstrated that the multimodal approach using 
18F-FMISO PET/CT and DCE-US has valuable diagnostic and 
prognostic potential for early non-invasive evaluation of 
radiotherapy. 
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The aim of this work is to study the effects of gold 
nanoparticles (GNPs) on cell viability in choroidal melanoma 
which is irradiated with cobalt source with Monte Carlo and 
In Vitro studies.  
In the Monte Carlo phase of this study a cylinder with the 
radius of 1.7 cm and the length of 2.1 cm was simulated as 
tumor phantom through with MCNP5 code and was filled with 
the tumor composition which obtained from previous work. In 
a discrete simulation such a phantom was divided into three 
parts and the middle region was latticed and filled with 
different concentrations of 50, 100, 200, 400 and 600 μg 
GNPs with 50nm in diameter. In both simulations the array of 
0.5*0.5*0.5 mm^3 voxels were utilized for scoring the 
average energy deposition to calculate the depth dose. The 
AECL Thetaron 60Co external radiation therapy device with 
the distance of 80 cm from the center of the Phantom has 
been considered as radiation source. The dose value to these 
voxels was calculated utilizing F6 tally. The dose 
enhancement factor (DEF) which is defined as the ratio of the 
dose in a particular region of a tissue when GNPs are present 
to the same factor in the absence of such substances were 
calculated and compared for different concentrations. In the 
in-vitro study, GNPs were synthesized following the FERN 
method, by employing HAuCl4 gold halides that were then 
reduced by sodium citrate. Cancerous melanoma cells were 
extracted from a middle-aged human female and digested by 
the use of the Tripezyn enzyme. The noted cells were 
cultured under a DMEM environment within a T75 flask with 
an FBS of 20%, and were incubated in an atmosphere 
consisting of 5% CO2, under a steady temperature of 37 C. 
Melanoma cells were cultured in a 96-well plate, and 
received the required GNPs with specific concentrations of 
600, 400, 200, 100 and 50μg through injection. The toxicity 
of the mentioned particles on the cells was then evaluated 
using a MTT Assay. The plate were then irradiated by the 
cobalt source in the presence and absence of GNPs. 48 hours 
and a week after irradiation, viability of the cells were 
assayed with MTT test again.  
In both Monte-Carlo and in-vitro studies it was observed that 
the presence of GNPs could play an important role in dose 
enhancement and decrease the viability of cancerous cells. 
When the concentration of nanoparticles increases in the 
area of the tumor, a higher amount of radiation energy will 
be absorbed in the tumor area. As a result, the amount of 
the dose absorbed by the normal tissue will be decreased.  
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Purpose: The effects of gold nanoparticles (GNPs) on human 
choroidal melanoma which are irradiated with a diode laser 
beam of 810nm wavelength has been examined with both 
Monte Carlo and In Vitro studies.  
Material and Method: In the Monte Carlo phase of this work, a 
human eye phantom has been simulated through with Geant4 
code and a tumor with the apical height of 0.5mm was 
defined on the equator temporal to the eyeball. The tumor 
was latticed by identical cubes each with a volume of 0.1cm3 
and different concentrations of gold nanoparticles were 
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defined within that. The dose enhancement factor (DEF) has 
been calculated to compare the effects of GNPs in laser 
therapy of eye melanoma. In the In Vitro phase of this work 
the uveal Melanoma cells were cultivated in DMEM with 20% 
FBS. In the seventh passage the cells were grown on a 24-
well plate in which the first five wells incubated with 
different concentrations of gold nanoparticles and the sixth 
well saved as control.  
Results and Discussion: The MTT assay was done in order to 
evaluate the toxicity of these nanoparticles, so as to define 
the preferred concentrations of GNPs. After the cytotoxicity 
assay and determination of the concentration range of these 
nanoparticles, the sample has been injected by GNPs, then 
the dosimetry has been done after irradiation of target with 
laser beam. Within a time span of 48 hours, and also a week 
after the injection of the noted substances, viability of cells 
were evaluated with MTT assay. The results show that the 
higher concentration of GNPs show a higher decrease in cell 
viability. Making a comparison between Laser beam, cobalt 
source and low dose rate sources such as Iodine and 
Palladium in the study of the effects of GNPs in cancer 
therapy reports very interesting results and motivated us to 
do a full in vivo study in this regards. Regarding the 
numerous sources that are employed in the radiotherapy of 
the eye Melanoma, the possible effects of these sources, 
whilst accompanied by GNPs, is a matter of heated debate in 
altering the period of treatment and requires more 
comprehensive investigations. A full experimental 
investigation of the effects of GNPs on Choroidal Melanoma 
against different radiation sources could answer this 
question.  
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Carbon ion therapy has been pioneered in USA since 1975[1], 
and in routine clinical use in Japan since 1994[2]. More 
recently, it has also been implemented in Europe (HIT, 
CNAO, MIT and soon MedAustron) and China, and more 
facilities are currently under planning worldwide[3]. The 
rationale behind hadrontherapy with carbon ions has to do 
with their better ballistic properties and higher LET (Linear 
Energy Transfer) when compared to the more widespread 
protons. The drawback being their greater complexity for 
production, planning and delivery[4]. 
Recent improvements in post-accelerated beam technology 
are expanding the range of beams available to include also 
radioactive nuclides, beyond the 12C ion species, currently 
utilized for carbon ion therapy[5]. Furthermore, Monte Carlo 
particle transport codes such as FLUKA[6,7], which has been 
used in this work, are becoming even more refined and 
therefore suitable for use in treatment planning and in-vivo 
verification techniques aiming to improve the treatment dose 
assessment[8].  
In this work, we systematically study the dosimetric 
performance and imaging properties of 11C in a water 
phantom. These add up to the advantages of conventional 12C 
ion therapy a stronger imaging signal, potentiating in-beam 
monitoring, and later dose intake assessment using PET 
instrumentation technologies. In addition to that, a similar 
study has been performed for 15O. 
FLUKA results confirmed the high potential of 11C and 15O in 
imaging, the former presenting no significant absorbed dose 
drawbacks compared to 12C.  
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Purpose: The molecule ODSH has shown great promise in 
preliminary studies suggesting that it improves platelet count 
recovery and impacts survival when the sodium form is given 
as a subcutaneous injection1. A new formulation of the 
molecule will be studied and radiation physics support will be 
provided to assure accuracy of the results. Expansion of the 
program for these studies will include performing dose 
ranging and PK/PD studies in mice for the novel formulation 
as well as some biology studies examining the biology of the 
mechanism of action of the molecule. The dosimetric studies 
will characterize the radiation source in terms of dose rate 
and energy. Maintaining the accuracy and precision of the 
radiation exposure throughout the project is a key factor to 
understanding the biological effects2. Dose uniformity and 
reproducibility will be monitored throughout the project to 
minimize dose uncertainty. 
Materials/Methods: Precision X-ray 3203 was calibrated 
following TG-61 protocol. EBT2 film was exposed at 200, 400, 
600 and 800 cGy to create calibration curve to be used in 
FilmProQA software developed by Ashland technologies. 
Mouse irradiations were taken 320kV, 12.5 mA to a total dose 
of 650 cGy. Gafchromic film was placed under the mice 
during irradiations and later analyzed with FilmProQA4 to 
determine accuracy and uncertainties during the experiment. 
Film exposures were taken at 800 cGy before each 
measurement to adjust the calibrations curve for daily 
variations of the x-ray tube. 
Results: Film analysis determined that dose uniformity in the 
irradiator can vary due to scatter and experimental setup and 
have an effect on the outcome of your experiment.  
Conclusions: For experiments with small animal irradiators a 
quality assurance program should be an integral part of any 
radiation biology study.  
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